Callitas Health Inc. Share Price Deutsche Boerse AG
Equities
T3F3
CA13125C1068
Biotechnology & Medical Research
Sales 2018 | 0.75 0.69 62.46 | Sales 2019 | 0.71 0.65 59.05 | Capitalization | 35.26L 32.49L 29Cr |
---|---|---|---|---|---|
Net income 2018 | -50L -46.06L -42Cr | Net income 2019 | -10L -9L -8.33Cr | EV / Sales 2018 | 48,52,616 x |
Net Debt 2018 | 3L 3L 2.66Cr | Net Debt 2019 | 8L 8L 7.06Cr | EV / Sales 2019 | 61,68,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03/18/03 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/14/01 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+44.48% | 5.4TCr | |
+43.57% | 4.2TCr | |
-0.86% | 4.19TCr | |
-7.59% | 2.84TCr | |
+12.30% | 2.64TCr | |
-21.83% | 1.9TCr | |
+7.15% | 1.3TCr | |
+29.40% | 1.23TCr | |
+25.15% | 1.22TCr |